Resources

Resources developed by IAS and its member societies
Imaging
Video Resource

Leading Insights: A Conversation with Professors Jessica M. Peña and Alexander van Rosendael

Watch the newest episode of IAS’ Leading Insights series to learn from Prof. Jessica M. Peña and Prof. Alexander van Rosendael as they discuss the latest study findings using CONFIRM2, the largest registry of quantification of atherosclerosis. IAS received an unrestricted grant from Cleerly to develop this resource. About Leading InsightsLeading Insights is a video series in which IAS’ global experts discuss recent research findings about breakthrough diagnostic tools, therapies and devices relevant to the diagnosis and management of […]

Leading Insights: A Conversation with Professors Jessica M. Peña and Alexander van Rosendael
Imaging
Infographic Resource

Understanding the Prognostic Value of AI-Based Quantitative Coronary CT

Artificial Intelligence Quantitative Computed Tomography (AI-QCT) uses AI technology to analyze the amount, composition, and stenosis of coronary artery plaque. IAS received an unrestricted grant from Cleerly to develop this resource.

Understanding the Prognostic Value of AI-Based Quantitative Coronary CT
Inflammation
Video Resource

Inflammation Academy Lecture Series

Recordings of the live lectures from the Inflammation Academy, held in Madrid on August 28, 2025

Inflammation Academy Lecture Series
Triglycerides
Infographic Resource

Formation of Triglycerides

This first graphic explains the formation of triglycerides and how their concentration in blood serves as a biomarker for TGRL, which promote the formation of atheroma.

Formation of Triglycerides
Triglycerides
Infographic Resource

Therapeutic Options for Severe Hypertriglyceridemia

This fourth graphic outlines the available therapeutic options for severe hypertriglyceridemia as well as novel therapies in development.

Therapeutic Options for Severe Hypertriglyceridemia
Triglycerides
Infographic Resource

Icosapent Ethyl for CV Risk Reduction

This fifth graphic delineates how icosapent ethyl can be used for CV risk reduction as demonstrated by the REDUCE-IT trial.

Icosapent Ethyl for CV Risk Reduction
Imaging
Video Resource

Atherosclerosis Webinar Series

Cleerly, the International Atherosclerosis Society, and Women As One, in collaboration with the Baim Institute for Clinical Research, have produced a webinar series designed to change how healthcare providers understand, detect, and manage coronary artery disease by going beyond symptoms and stenosis to the true biology of atherosclerosis. Episode 1: Atherosclerosis: Basic Concepts and Current Understanding Presented by […]

Atherosclerosis Webinar Series

Promoting the scientific understanding of atherosclerosis

Newsletters

Stay in touch with IAS